HOME >> BIOLOGY >> NEWS
Jefferson Scientists Suppress Tumor Growth In Animals, Aiming At Gene Therapy

Scientists at Jefferson Medical College believe they have taken the next step toward gene therapy trials for lung cancer. They have demonstrated for the first time in laboratory animals that a normally protective anticancer gene, pRb2/p130, can actually block tumors from growing. A damaged version of the gene, termed a "tumor suppressor," has been implicated in several cancers, such as lung, breast and endometrial.

Previous test tube experiments had proven that tumors wouldn't grow when the gene--and its protein product--were present. But 'curing cancer' in the test tube is one thing. Now that they've found the gene stops cancer formation in an animal model, the next step would be to understand how the gene and its protein actually work. Eventually, the scientists, led by Antonio Giordano, M.D., Ph.D., associate professor of pathology, anatomy and cell biology at Thomas Jefferson University in Philadelphia, would like to develop a gene therapy procedure against Rb2 to treat cancer.

Verifying Rb2's function, Dr. Giordano says, "shows the complexity of cancer. It's clear that Rb2 is one of a small number of tumor suppressor genes that play important roles in cancer," he says. "We know now that Rb2 can be therapeutically powerful. Understanding how they work is key to solving the puzzle of cancer formation. We think that Rb2 is used in combination with other tumor suppressor genes."

Dr. Giordano and his colleagues at Allegheny University of the Health Sciences and the University of Naples report their results October 7 in the Journal of the National Cancer Institute. "The importance of this work is that it's the first time we have shown that the tumor suppressor, pRb2/p130, is able to suppress tumor growth in mice," says Dr. Giordano. "In the past, we only showed that Rb2 could suppress cancer cell lines from growing. Now we find it dramatically does so on mice. It's a very exciting study to sh
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-6300
Thomas Jefferson University
6-Oct-1998


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: